-Cardinal Health Inc. (CAH) is well-poised for growth, given its acquisition-driven strategy, a diversified product portfolio and a robust pharmaceutical segment. However, inflationary pressure remains a concern.Shares of this Zacks Rank #3 (Hold) company have risen 1.5% in the year-to-date period compared with the industry’s 0.1% growth. The S&P 500 Index has gained 11.7% in the same time frame.          CAH, with a market capitalization of $27.49 billion, is a nationwide drug distributor and service provi ...